Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Altmann

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchangeMelissa J Call, Xuechao Xing, Gregory D Cuny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2019
Bioluminescent Reporting of In Vivo IFN-γ Immune Responses during Infection and AutoimmunityCatherine J Reynolds, Deborah L W Chong, Yihan Li, et al.
The Journal of Biological Chemistry|April 26, 2015
Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like DiseaseNathali Kaushansky, Miriam Eisenstein, Sigalit Boura-Halfon, et al.
Lancet (London, England)|February 28, 2021
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individualsCharlotte Manisty, Ashley D Otter, Thomas A Treibel, et al.
Arthritis Research & Therapy|May 18, 2006
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic miceAlexei von Delwig, Catharien M U Hilkens, Daniel M Altmann, et al.
Nature Communications|March 6, 2024
Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosisMikias Negash, Menberework Chanyalew, Tigist Girma, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Journal of Neuroinflammation|January 4, 2012
Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Pascal F Durrenberger, Anna Ettorre, Fatemah Kamel, et al.
Immunology|June 4, 2014
The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II allelesCatherine J Reynolds, Claire Jones, Christoph J Blohmke, et al.
Plos Computational Biology|March 9, 2016
BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot DataLies Boelen, Patrick K O'Neill, Kathryn J Quigley, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchangeMelissa J Call, Xuechao Xing, Gregory D Cuny, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 2019
Bioluminescent Reporting of In Vivo IFN-γ Immune Responses during Infection and AutoimmunityCatherine J Reynolds, Deborah L W Chong, Yihan Li, et al.
The Journal of Biological Chemistry|April 26, 2015
Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like DiseaseNathali Kaushansky, Miriam Eisenstein, Sigalit Boura-Halfon, et al.
Lancet (London, England)|February 28, 2021
Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individualsCharlotte Manisty, Ashley D Otter, Thomas A Treibel, et al.
Arthritis Research & Therapy|May 18, 2006
Inhibition of macropinocytosis blocks antigen presentation of type II collagen in vitro and in vivo in HLA-DR1 transgenic miceAlexei von Delwig, Catharien M U Hilkens, Daniel M Altmann, et al.
Nature Communications|March 6, 2024
Evidence for immune activation in pathogenesis of the HLA class II associated disease, podoconiosisMikias Negash, Menberework Chanyalew, Tigist Girma, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 11, 2009
A role of cellular prion protein in programming T-cell cytokine responses in diseaseRebecca J Ingram, Jeremy D Isaacs, Gurman Kaur, et al.
Journal of Neuroinflammation|January 4, 2012
Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1)Pascal F Durrenberger, Anna Ettorre, Fatemah Kamel, et al.
Immunology|June 4, 2014
The serodominant secreted effector protein of Salmonella, SseB, is a strong CD4 antigen containing an immunodominant epitope presented by diverse HLA class II allelesCatherine J Reynolds, Claire Jones, Christoph J Blohmke, et al.
Plos Computational Biology|March 9, 2016
BIITE: A Tool to Determine HLA Class II Epitopes from T Cell ELISpot DataLies Boelen, Patrick K O'Neill, Kathryn J Quigley, et al.
Pageof 15